HumeCare+ review

The page is titled Microdose GLP-1 Rx Program and there is no milligram figure on it, nor on the plan card, nor on the checkout, which says only that your provider sets the final dose. That is the whole reason this row exists here: naming a product a microdose is not the same as publishing what it contains, and this is the clearest example here of the two being confused. What HumeCare does that almost nobody else does is measure the thing GLP-1 treatment is criticized for costing you — a body analyzer arrives with the medication, at no separate charge, and reads fat mass and lean muscle every week so the clinician titrates against body composition rather than the scale. Set against that: no figure of any kind is reachable before you answer the medical questionnaire, the advertised rate is a floor with a non-refundable consultation fee charged at signup and at every refill, and the money-back promise in the marketing is a narrower guarantee in the contract. We are not paid by HumeCare, so the link below is a plain one to its own page.

Vs median

$30/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

No low-dose price published

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Varies by dose, plan or tier

Price last updated

August 2026

HumeCare+ does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

An online medical questionnaire leads to a checkout that prices three products: compounded semaglutide by injection at $199 a month, the same molecule orally at $199, and compounded tirzepatide blended with vitamin B12 and glycine at $299. Each is billed monthly with no minimum term, and each card lists medication, prescription, provider consultation, shipping and 24/7 clinical support as included. What arrives alongside the medication is the part no other row here offers: a Hume Pod body analyzer, which the company values at $350 and gives at no extra cost, reading fat mass, lean muscle and metabolic age every week so the clinician titrates against body composition rather than scale weight.

No milligram figure is published anywhere — including on the page titled "Microdose GLP-1 Rx Program" and at the checkout, which says only that the provider sets the final dose. Nothing published anywhere tells you what dose $199 buys

• No price is reachable without answering the medical questionnaire: the homepage carries no figure at all, so the cost is unknowable until you have handed over a medical history
• The advertised figure is a floor. Its terms charge a non-refundable clinical consultation fee at enrollment and at every refill, never say what that fee is, and reserve the right to charge more for certain dosages or formulations at the company's sole discretion
• Marketing offers a "180 days Money Back Promise"; the contract offers a 90-day guarantee that pays out only if you achieved no measurable weight loss at all, excludes that consultation fee, and requires you to have never taken a GLP-1 before
• Names no pharmacy, states no 503A or 503B compounding designation, and publishes no state list behind "not available in all 50 states"

HumeCare+ is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• Low dose vs full dose
• What microdosing GLP-1 costs
• Microdose & reconstitution calculator
• Titration planner